Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Histrelin (Supprelin LA / Vantas) vs Insulin Glargine (Lantus)
An educational, source-based comparison of Histrelin (Supprelin LA / Vantas) and Insulin Glargine (Lantus) — how each peptide works, what it's researched for, and what to know before going deeper.
GnRH agonist implant for central precocious puberty and prostate cancer.
Synthetic nonapeptide GnRH agonist delivered via a subcutaneous hydrogel implant providing continuous release for 12 months, desensitizing the pituitary and suppressing sex steroids.
- Central precocious puberty (Supprelin LA)
- Advanced prostate cancer (Vantas)
- • FDA-approved.
- • Implant site reactions and rare implant breakage at removal.
Long-acting basal insulin analog for type 1 and type 2 diabetes.
Recombinant human insulin analog with two arginine residues added to the B-chain and asparagine→glycine at A21, forming microprecipitates at injection site for ~24-hour glucose-lowering activity via insulin receptor activation.
- Type 1 diabetes basal coverage
- Type 2 diabetes basal insulin therapy
- Gestational diabetes
- • FDA-approved.
- • Hypoglycemia and weight gain are primary risks.
- • Do not mix with other insulins.
Histrelin (Supprelin LA / Vantas) vs Insulin Glargine (Lantus) — Key differences
- Class: Histrelin (Supprelin LA / Vantas) is classified as GnRH Agonist · Endocrine, while Insulin Glargine (Lantus) is Insulin Analog · Endocrine.
- Primary research focus: Histrelin (Supprelin LA / Vantas) — central precocious puberty (supprelin la); Insulin Glargine (Lantus) — type 1 diabetes basal coverage.
- Tag: FDA-Approved · Endocrine vs FDA-Approved · Diabetes.